CIDRAP newsletters options
One clade of eight RSV-B genomes had a mutation tied to resistance to the monoclonal antibody nirsevimab.
The case-patient recently traveled abroad, but few other details were given by the institute.
The variant appears to have greater infectivity and immune-evasion properties, which could help it edge out KP.3.1.1.
The virus has an enzyme that can efficiently circumvent a host cell's innate defense mechanism.
Two patients who were intubated for multiple organ failure were successfully extubated, thought to be a first in Africa for Marburg.
The spurt of infections in Washington state is reminiscent of what Colorado experienced over the summer with illnesses in poultry cullers.
The authors said they observed distinct regional patterns to norovirus outbreaks in the state.
After surging during the pandemic, rates of carbapenem-resistant gram-negative bacteria in critically ill patients have declined but remain higher than pre-pandemic rates.
The Italian government will contribute $21 million over 3 years to support CARB-X’s efforts to advance early-stage development of innovative new products for drug-resistant pathogens.
The probe detected the biomarker for H5N1 at three treatment plants, with two confirming that animal protein had already left processing facilities such as dairy farms.
Safety and immunogenicity profiles were similar to those seen in adult studies.
The authors said the findings should encourage people to get vaccinated against RSV this year.
The unadjusted median time to symptom resolution was 10 days in both the intervention and placebo groups.
The CDC said the rise in M pneumoniae in children ages 2 to 4 is notable, because it isn't typically known as a leading cause of pneumonia in the age-group.
A trial conducted in 7 countries found that a 7-day course of antibiotics for patients with bloodstream infections is non-inferior to a 14-day course.
An electronic health record order set that pre-selected a 5-day antibiotic course for children with acute otitis media improved compliance with treatment guidelines by 80%.
The first phase of Nigeria's campaign will begin in November, targeting Kebbi and Beyelsa states, where malaria activity is especially high.
Health officials in the DRC are making progress with administering vaccine to high-risk people, as Nigeria expect to start its campaign next week.
Exemptions rose in 41 states, with 14 reporting that over 5% of kindergartners had an exemption from at least one vaccine.
Detection of the NDM gene, which confers resistance to multiple antibiotic classes, in blood cultures of hospitalized patients was associated with 48% mortality.
